This inventor holds 2 USPTO granted patents. Top assignees: 3 Q B D Ltd., Q-Scent Ltd.. Active years: 2006-2011.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2006-2011
Title: Avraham Lorber: Innovator in Diagnostic Methods
Introduction
Avraham Lorber is a notable inventor based in Metar, Israel. He has made significant contributions to the field of diagnostic assessment through his innovative methods and apparatus. With a total of 2 patents, Lorber's work focuses on the analysis of biogenic amines in body fluids and other samples.
Latest Patents
Lorber's latest patents include methods and apparatus for diagnostic assessment based on amounts of biogenic amines. These diagnostic methods derive a number of measured parameters related to the desired diagnostic information from the amounts of biogenic amines contained in a sample. For each desired diagnostic information, an input identifying the information is provided. This input is then compared to the measured parameters to derive a diagnostic response. The parameters may be derived according to a program stored in memory. Additionally, the detection of less volatile amines can be enhanced by successively adding a base and an acid to the sample and analyzing the emitted vapors under heating.
Career Highlights
Throughout his career, Avraham Lorber has worked with various companies, including Q-Scent Ltd. and 3QBD Ltd. His experience in these organizations has contributed to his expertise in diagnostic technologies and methods.
Collaborations
Lorber has collaborated with notable individuals in his field, including Zeev Karpas. Their partnership has likely fostered advancements in the diagnostic methods they have developed.
Conclusion
Avraham Lorber's innovative work in diagnostic assessment showcases his commitment to improving medical diagnostics through technology. His patents reflect a deep understanding of biogenic amines and their significance in health assessments.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile